Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

EDI-MSK Equitable musculoskeletal health driven by inclusive models

Coordinator
University of Leeds, United Kingdom
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€4.6m
Total cost
—
Partners
20 organisations in 11 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101311648

What the project is doing

In the project's own words, from its summary on CORDIS.

Musculoskeletal (MSK) disorders are a leading global cause of disability, affecting people of all demographics (age, gender, ethnicity…) and contributing significantly to reduced quality of life, loss of productivity and healthcare costs. The complexity of their pathophysiology across scales eludes healthcare professionals, and treatments remain mostly palliative with predominantly one-size-fits-all approaches. As the concept of digital twins in health develops, in silico modelling and simulation provides unique opportunities to integrate heterogeneous information coherently, for precise stratification and targeted treatment and prevention.

However, and despite the broad impact of MSK disorders, the models simulating MSK function and disease remain largely derived from homogeneous data biased, as per sex, age, health status, and ethnics. This lack of diversity limits applications in precision medicine and risks reinforcing systemic healthcare inequities in diagnosis and treatment. The EDI-MSK MSCA Doctoral Network aims to train a new generation of professionals in in silico medicine with expert culture and skills to include diversity at the core of model developments for MSK health and disease, across scales.

Specifically, by using data from experiments, and from population and patient cohorts, stratified by sex, age, and co-morbidities, also integrating social sciences and coproduction with communities, the DN will uniquely define diversity hallmarks to be incorporated into MSK models. It will generate and test methodological blueprints to incorporate life habits, sex, including women’s health, age, rare and chronic disease, and ethnicity.

The EDI-MSK consortium includes seven beneficiaries and 13 associated partners. It benefits from the experience of non-profit institutions and SME that are significant players in the in silico medicine ecosystem and will make the EDI-MSK Doctoral Candidates become leaders of the transformation of MSK model towards inclusivity.

Topics

Who is involved

OrganisationCityCountryRole
University of LeedsLeedsUnited KingdomCoordinator
University of MelbourneMelbourneAustraliaAssociatedpartner
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Replasia BVLeuvenBelgiumAssociatedpartner
Virtual Physiological Human Institute for Integrative Biomedical Research VzwHeverleeBelgiumParticipant
The University of Western OntarioOntario - LondonCanadaAssociatedpartner
Esqlabs GmbHSaterlandGermanyAssociatedpartner
Universidad Pompeu FabraBarcelonaSpainParticipant
TwinsightLa TroncheFranceAssociatedpartner
Universita Degli Studi Di PadovaPadovaItalyParticipant
Technische Universiteit DelftDelftNetherlandsParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant
Universiteit UtrechtUtrechtNetherlandsAssociatedpartner
Nhs Blood and TransplantWatfordUnited KingdomAssociatedpartner
Simulation Solutions LimitedHeaton MerseyUnited KingdomAssociatedpartner
The Leeds Teaching Hospitals National Health Service TrustLeedsUnited KingdomAssociatedpartner
Black Biomechanists AssociationSalisburyUnited StatesAssociatedpartner
International Women in Biomechanics, Inc.DundalkUnited StatesAssociatedpartner
latinx in BiomechanixUrbanaUnited StatesAssociatedpartner
University of Cape TownRondeboschSouth AfricaAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI